A response-tailored strategy reduced antibiotic duration by two weeks without compromising the safety of patients with left-sided infective endocardi1
READ MOREThe first-ever European Society of Cardiology Guidelines on the management of cardiovascular disease and chronic kidney disease have been developed i1
READ MORE
Aficamten treatment was associated with significant improvements in symptom burden and exercise capacity in patients with symptomatic non-obstru1
READ MORE